AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection.


Journal

European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201

Informations de publication

Date de publication:
02 2022
Historique:
revised: 21 10 2021
received: 12 08 2021
accepted: 22 11 2021
pubmed: 26 11 2021
medline: 8 2 2022
entrez: 25 11 2021
Statut: ppublish

Résumé

A late presenter AIDS patient with severe T cell depletion presented non-severe COVID-19 symptoms, with prolonged viral shedding. Our case report supports the hypothesis that an effective T cell response may be dispensable for the control of COVID-19 progression to severe forms, while it may be necessary for SARS-CoV-2 clearance.

Identifiants

pubmed: 34822185
doi: 10.1002/eji.202149574
pmc: PMC9015404
doi:

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

352-355

Informations de copyright

© 2021 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.

Références

AIDS. 2021 Mar 15;35(4):F1-F10
pubmed: 33587448
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
N Engl J Med. 2020 Dec 24;383(26):2586-2588
pubmed: 33259154
AIDS. 2020 Nov 1;34(13):F3-F8
pubmed: 32796217
Pediatr Allergy Immunol. 2020 Jul;31(5):565-569
pubmed: 32319118
Clin Infect Dis. 2021 Jan 27;72(2):340-350
pubmed: 33501974
Nat Genet. 2020 Oct;52(10):991-998
pubmed: 32908258
Lancet HIV. 2021 May;8(5):e294-e305
pubmed: 33915101
Transfus Apher Sci. 2020 Oct;59(5):102871
pubmed: 32694044
Nature. 2021 Apr;592(7853):277-282
pubmed: 33545711
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
AIDS. 2008 Apr 23;22(7):841-8
pubmed: 18427202
Br J Haematol. 2020 Aug;190(3):e154-e156
pubmed: 32593180
J Infect Dis. 2021 Jan 4;223(1):23-27
pubmed: 33089317
Eur J Immunol. 2021 Nov;51(11):2651-2664
pubmed: 34424997
Mult Scler Relat Disord. 2020 Jul;42:102185
pubmed: 32408147
Cell. 2021 Apr 29;184(9):2332-2347.e16
pubmed: 33761326

Auteurs

Michele Spinicci (M)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.

Alessio Mazzoni (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Beatrice Borchi (B)

Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.

Lucia Graziani (L)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Marcello Mazzetti (M)

Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.

Filippo Bartalesi (F)

Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.

Annarita Botta (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Marta Tilli (M)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Filippo Pieralli (F)

Intermediate Care Unit, Careggi University Hospital, Florence, Italy.

Marco Coppi (M)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Nicla Giovacchini (N)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Maria Grazia Colao (MG)

Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.

Riccardo Saccardi (R)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Department of Cellular Therapies and Transfusion Medicine, Careggi University Hospital, Florence, Italy.

Gian Maria Rossolini (GM)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.

Francesco Annunziato (F)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Flow Cytometry Diagnostic Center and Immunotherapy (CDCI), Careggi University Hospital, Florence, Italy.

Alessandro Bartoloni (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH